Abstract |
Expression of AP-1 proteins has been associated with a more aggressive clinical outcome in prostate cancer. However, their role and regulation by upstream kinase pathways in response to ionizing radiation has remained elusive. Here, we show that constitutive AP-1 activity in prostate cancer cells is dependent on the activities of EGF-R and PI3K. While inhibition of EGF-R is associated with suppression of c-Jun expression and proliferation, inhibition of PI3K pathway suppresses expression of several AP-1 subunits and proliferation, and also sensitizes prostate cancer cells to gamma-radiation. The importance of AP-1 as a mediator of proliferation and radiation responses is demonstrated by the findings that the expression of JunD, Fra-1 and Fra-2 siRNAs in prostate cancer cells suppress these cellular responses. Together, the findings show that AP-1 activity in prostate cancer cells mediates EGF-R and PI3K signalling, is essential for their proliferation, and confers protection against radiation-induced cell death. Thus, its inhibition would be a lucrative target for therapy in this widely increasing cancer type.
|
Authors | Risto Kajanne, Päivi Miettinen, Mikko Tenhunen, Sirpa Leppä |
Journal | International journal of oncology
(Int J Oncol)
Vol. 35
Issue 5
Pg. 1175-82
(Nov 2009)
ISSN: 1791-2423 [Electronic] Greece |
PMID | 19787273
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Transcription Factor AP-1
- Phosphatidylinositol 3-Kinases
- ErbB Receptors
|
Topics |
- Apoptosis
(genetics, radiation effects)
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation
(radiation effects)
- Electrophoretic Mobility Shift Assay
- ErbB Receptors
(genetics, metabolism)
- Humans
- Male
- Phosphatidylinositol 3-Kinases
(genetics, metabolism)
- Prostatic Neoplasms
(genetics, metabolism, pathology)
- Radiation Tolerance
(genetics)
- Signal Transduction
(genetics, radiation effects)
- Transcription Factor AP-1
(genetics, metabolism)
|